2.66
price up icon3.50%   0.09
after-market 시간 외 거래: 2.63 -0.03 -1.13%
loading
전일 마감가:
$2.57
열려 있는:
$2.6
하루 거래량:
56,336
Relative Volume:
0.11
시가총액:
$51.83M
수익:
-
순이익/손실:
$-40.94M
주가수익비율:
-0.6927
EPS:
-3.84
순현금흐름:
$-22.97M
1주 성능:
-2.92%
1개월 성능:
+0.76%
6개월 성능:
-47.95%
1년 성능:
-75.02%
1일 변동 폭
Value
$2.59
$2.66
1주일 범위
Value
$2.52
$2.8899
52주 변동 폭
Value
$1.11
$11.69

Annovis Bio Inc Stock (ANVS) Company Profile

Name
명칭
Annovis Bio Inc
Name
전화
484-875-3192
Name
주소
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Name
직원
6
Name
트위터
Name
다음 수익 날짜
2024-12-11
Name
최신 SEC 제출 서류
Name
ANVS's Discussions on Twitter

ANVS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ANVS
Annovis Bio Inc
2.66 50.08M 0 -40.94M -22.97M -3.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-10 다운그레이드 D. Boral Capital Buy → Hold
2024-10-25 업그레이드 Maxim Group Hold → Buy
2023-12-29 개시 Canaccord Genuity Buy
2021-07-07 재확인 Maxim Group Buy

Annovis Bio Inc 주식(ANVS)의 최신 뉴스

pulisher
02:59 AM

What analysts say about Annovis Bio Inc. stockFree Capital Allocation Plans - Autocar Professional

02:59 AM
pulisher
04:42 AM

What drives Annovis Bio Inc. stock priceMassive portfolio appreciation - jammulinksnews.com

04:42 AM
pulisher
01:14 AM

Is Annovis Bio Inc. a good long term investmentExplosive earnings growth - jammulinksnews.com

01:14 AM
pulisher
Jul 22, 2025

Annovis Bio Inc. Stock Analysis and ForecastSuperior investment outcomes - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Annovis Bio stock rating cut to hold at D. Boral Capital - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Annovis Bio to Present Key Findings at Alzheimer’s Association International Conference - MSN

Jul 22, 2025
pulisher
Jul 18, 2025

What risks could impact Annovis Bio Inc. stock performanceCapital Growth Picks - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Annovis Bio Inc. Advances Alzheimer’s Treatment with Buntanetap Study - TipRanks

Jul 16, 2025
pulisher
Jul 15, 2025

Why Annovis Bio Inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Annovis Bio Inc. stock price move sharplyFree Popular Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Annovis Bio Inc. stock performs during market volatilityCapital Growth Picks - newser.com

Jul 15, 2025
pulisher
Jul 12, 2025

Annovis Bio's Volatility Trap: Why Risky Bets and Biotech Headwinds Spell Caution for Investors - AInvest

Jul 12, 2025
pulisher
Jul 04, 2025

Annovis Bio Advances Phase 3 Alzheimer’s Trial Amid Steady Financial Progress - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Parkinson's Disease Clinical and Non-Clinical Studies, Key - openPR.com

Jul 03, 2025
pulisher
Jun 30, 2025

Annovis Bio’s Alzheimer’s Study: A Potential Game-Changer for Investors? - TipRanks

Jun 30, 2025
pulisher
Jun 26, 2025

Annovis Bio Inc. to Showcase Alzheimer’s Research at AAIC 2025 - citybuzz -

Jun 26, 2025
pulisher
Jun 25, 2025

Annovis Bio Plunges 10.13% on Analyst Price Target Cut - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Annovis Bio (ANVS) Stock Jumps Over 16% in Market Trading | ANVS Stock News - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

Annovis Bio to Host Webcast on June 24, 2025, Featuring Updates on Phase 3 AD Trial and PD Program Development - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

Annovis Bio Approves Board Elections and Auditor Appointment - TipRanks

Jun 23, 2025
pulisher
Jun 22, 2025

We Think Annovis Bio (NYSE:ANVS) Needs To Drive Business Growth Carefully - Yahoo Finance

Jun 22, 2025
pulisher
Jun 20, 2025

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Gains 18-Month NYSE Compliance Window - FinancialContent

Jun 20, 2025
pulisher
Jun 19, 2025

Annovis Bio Secures NYSE Approval to Regain Compliance with Listing Standards - MSN

Jun 19, 2025
pulisher
Jun 19, 2025

Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance - The Manila Times

Jun 19, 2025
pulisher
Jun 14, 2025

10,923 Shares in Annovis Bio, Inc. (NYSE:ANVS) Bought by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

All You Need to Know About Annovis Bio (ANVS) Rating Upgrade to Buy - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

HC Wainwright Has Optimistic View of Annovis Bio Q2 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Q1 Earnings Forecast for Annovis Bio Issued By HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Annovis Bio (NYSE:ANVS) Price Target Cut to $12.00 by Analysts at HC Wainwright - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Annovis Bio (ANVS) Price Target Cut by 60% by HC Wainwright | AN - GuruFocus

Jun 09, 2025

Annovis Bio Inc (ANVS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
자본화:     |  볼륨(24시간):